“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Antiplatelet effects of a new sucralfate-coated aspirin formulation

Antiplatelet effects of a new sucralfate-coated aspirin formulation The purpose of this study was to determine whether the antiplatelet effects of a 100-mg aspirin tablet coated with sucralfate 200 mg in a new formulation given once daily for 14 days to patients with platelet hyperaggregation were comparable to those produced after administration of a standard enteric-coated preparation containing the same amount of aspirin. Forty patients (23 women, 17 men), aged 30 to 70 years, were enrolled in the study and randomly assigned to either treatment group. Both drugs were administered for 14 days at a dose of one tablet daily. Platelet aggregation in the presence of adenosine diphosphate or epinephrine and thromboxane plasma levels were compared for variations within and between treatment groups at baseline, and at 7 and 14 days after treatment. Both treatments produced significant antiplatelet effects as evidenced by functional platelet aggregation studies, as well as by a reduction in thromboxane production. These effects occurred in patients randomly allocated to receive the enteric-coated as well as the sucralfate-coated aspirin formulations, thus showing the therapeutic bioequivalence of the two formulations on platelet hyperaggregation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Therapeutic Research Elsevier
Loading next page...
 
/lp/elsevier/antiplatelet-effects-of-a-new-sucralfate-coated-aspirin-formulation-GWIBRXkPP6

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.